Frontier Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$83.7M |
| 2 |
Humana
HUM
|
+$52.3M |
| 3 |
QLGC
QLOGIC CORP
QLGC
|
+$49.1M |
| 4 |
Designer Brands
DBI
|
+$45.5M |
| 5 |
Puma Biotechnology
PBYI
|
+$43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$104M |
| 2 |
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
|
+$97.1M |
| 3 |
Aptiv
APTV
|
+$82.1M |
| 4 |
ATML
ATMEL CORP
ATML
|
+$66M |
| 5 |
ITMN
INTERMUNE INC
ITMN
|
+$57.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.8% |
| 2 | Technology | 18.17% |
| 3 | Healthcare | 11.61% |
| 4 | Financials | 11.28% |
| 5 | Consumer Discretionary | 9.79% |
Similar funds
Frontier Capital Management's Q3 2014 Portfolio in Review
As of Q3 2014, Frontier Capital Management held 358 positions worth $12.4B, down 8.6% from $13.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Frontier Capital Management withdrew a net $425M in Q3 2014, closing 11 positions and reducing 171 holdings. Its most notable exit was INTERMUNE INC, an estimated $57.5M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Frontier Capital Management opened a new position in Humana worth $53.6M.
- Frontier Capital Management's largest Q3 2014 buy was Humana: 411,770 shares worth $53.6M.
- Frontier Capital Management added most to Centene in Q3 2014, an estimated $83.7M increase.
- Frontier Capital Management's biggest Q3 2014 reduction was Allergan plc, cutting an estimated $104M.
- Frontier Capital Management fully exited INTERMUNE INC in Q3 2014, selling an estimated $57.5M.
- Frontier Capital Management's ten largest holdings make up 13% of its $12.4B portfolio in Q3 2014.
- Frontier Capital Management opened 14 new positions and closed 11 in Q3 2014.
- Frontier Capital Management's portfolio value fell 8.6% quarter-over-quarter to $12.4B.
Based on Frontier Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.